Default: Nature Reviews Neurology

ISSN: 1759-4758

Journal Home

Journal Guideline

Nature Reviews Neurology Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nature Reviews Neurology is a journal indexed in SJR in Neurology (clinical) and Cellular and Molecular Neuroscience with an H index of 150. It has an SJR impact factor of 7,271 and it has a best quartile of Q1. It has an SJR impact factor of 7,271.

Nature Reviews Neurology focuses its scope in these topics and keywords: activity, alzheimer, disease, brain, clinical, early, epilepticusa, epileptiform, drug, diseaseminimally, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

Nature Reviews Neurology

7,271

SJR Impact factor

150

H Index

134

Total Docs (Last Year)

499

Total Docs (3 years)

8180

Total Refs

5075

Total Cites (3 years)

273

Citable Docs (3 years)

10,68

Cites/Doc (2 years)

61,04

Ref/Doc

Aims and Scope


activity, alzheimer, disease, brain, clinical, early, epilepticusa, epileptiform, drug, diseaseminimally, emerging, formation, frontotemporal, glioblastoma, gliomanmo, immature, injury, intelligence, invasive, drives, disorders, bloodgabaergic, carecompound, cellsepileptogenesis, cerebrospinal, chemotherapyresistant, classificationselfprojection, convulsive, default, dementia, dementiabiomarkers, developmenttowards, diagnosis, disability,


Best articles

'Time is brain' after stroke, regardless of age and severity

View more

A new therapeutic strategy in epileptic seizure suppression

View more

A new window of opportunity for stroke rehabilitation?

View more

A role for serotonergic neurons in levodopa-induced dyskinesia

View more

A step towards clinical blood biomarkers of glioblastoma

View more

Age at injury influences dementia risk after TBI

View more

Altered functional connectivity in preclinical dementia

View more

Atacicept increases relapse rates in multiple sclerosis

View more

Autism mutation produces hyper-connected neurons

View more

Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders

View more

Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma

View more

Biological fluid biomarkers in neurodegenerative parkinsonism

View more
SHOW MORE ARTICLES

Biomarkers for ALS - in search of the Promised Land

View more

Biomarkers predict conversion from MCI to AD

View more

Blocking mitochondrial fission - a new treatment approach for Parkinson disease?

View more

Calcium channel blockers and Parkinson disease

View more

Can neuroimaging studies identify pain endophenotypes in humans?

View more

Can Pittsburgh compound B PET imaging quantify demyelination in MS?

View more

Carotid stenosis - surgery or stenting to prevent stroke?

View more

Clinical exome sequencing in neurology practice

View more

Correction: Cell-to-cell transmission of non-prion protein aggregates

View more

Cortical connectivity predicts success of stroke rehabilitation

View more

CSF biomarkers differentiate between two forms of frontotemporal lobar degeneration

View more

CSF biomarkers for Alzheimer disease - approaching consensus

View more

Comments

No comments ... Be the first to comment!